In Brief This Week: Invitae, Danaher, Fulgent Genetics, and More

NEW YORK – Invitae on April 6 closed an underwritten public offering that brought in approximately $172.5 million in net proceeds. In a filing with the US Securities and Exchange Commission, Invitae said it sold about 17.8 million shares of common stock at a price of $9.00 per share. The offering's underwriters exercised their option to purchase an additional 2. 7 million shares..